Regional Variation across Canadian Centers in Radioiodine Administration for Thyroid Remnant Ablation in Well-Differentiated Thyroid Cancer Diagnosed in 2000–2010

Figure 1

Distribution of RAI preparation (rhTSH versus THW) for patients with differentiated thyroid cancer that received radioactive iodine in the period from 2000 to 2010. Data for each year are obtained by combining all patients from all centers diagnosed in each year. rhTSH: recombinant human thyroid stimulating hormone; THW: thyroid hormone withdrawal.